Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016 (2016), Article ID 2601740, 9 pages
http://dx.doi.org/10.1155/2016/2601740
Review Article

The Effects of Chunghyul-Dan (A Korean Medicine Herbal Complex) on Cardiovascular and Cerebrovascular Diseases: A Narrative Review

Department of Cardiology and Neurology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea

Received 16 February 2016; Revised 22 April 2016; Accepted 4 May 2016

Academic Editor: Yong C. Boo

Copyright © 2016 Woo-Sang Jung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y.-S. Kim, E.-A. Jung, J.-E. Shin et al., “Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase,” Biological and Pharmaceutical Bulletin, vol. 25, no. 11, pp. 1442–1445, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Kwon, W. Jung, A. R. Byun, S. Moon, K. Cho, and K. Shin, “Administration of Hwang-Ryun-Haedok-tang, a herbal complex, for patients with abdominal obesity: a case series,” Explore, vol. 11, no. 5, pp. 401–406, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Arakawa, T. Saruta, K. Abe et al., “Improvement of accessory symptoms of hypertension by TSUMURA Orengedokuto Extract, a four herbal drugs containing Kampo-Medicine Granules for ethical use: a double-blind, placebo-controlled study,” Phytomedicine, vol. 13, no. 1-2, pp. 1–10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Oshima, Y. Narukawa, N. Hada, and F. Kiuchi, “Quantitative analysis of anti-inflammatory activity of orengedokuto: importance of combination of flavonoids in inhibition of PGE2 production in mouse macrophage-like cell line J774.1,” Journal of Natural Medicines, vol. 67, no. 2, pp. 281–288, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Ikarashi, M. Tajima, K. Suzuki et al., “Inhibition of preadipocyte differentiation and lipid accumulation by Orengedokuto treatment of 3T3-L1 cultures,” Phytotherapy Research, vol. 26, no. 1, pp. 91–100, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Kimura, M. Shimizu, S. Kohara, F. Yoshii, H. Sato, and Y. Shinohara, “Antiplatelet effects of a Kampo medicine, Orengedokuto,” Journal of Stroke and Cerebrovascular Diseases, vol. 15, no. 6, pp. 277–282, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. S. Hwang, C. Y. Shin, Y. Huh, and J. H. Ryu, “Hwangryun-Hae-Dok-tang (Huanglian-Jie-Du-Tang) extract and its constituents reduce ischemia-reperfusion brain injury and neutrophil infiltration in rats,” Life Sciences, vol. 71, no. 18, pp. 2105–2117, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Zhang, Z. Qian, L. Pan, H. Li, and H. Zhu, “Hypoxia-inducible factor 1 mediates the anti-apoptosis of berberine in neurons during hypoxia/ischemia,” Acta Physiologica Hungarica, vol. 99, no. 3, pp. 311–323, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Higashino, Y. Sasaki, J. C. Giddings et al., “Crocetin, a carotenoid from Gardenia jasminoides Ellis, protects against hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats,” Phytotherapy Research, vol. 28, no. 9, pp. 1315–1319, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. R. H. Hughes, V. A. Silva, I. Ahmed, D. I. Shreiber, and B. Morrison III, “Neuroprotection by genipin against reactive oxygen and reactive nitrogen species-mediated injury in organotypic hippocampal slice cultures,” Brain Research, vol. 1543, pp. 308–314, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Y. Chow, J. C. C. Wang, and K. K. Cheng, “Cardiovascular effects of Gardenia florida L. (Gardeniae fructus) extract,” The American Journal of Chinese Medicine, vol. 4, no. 1, pp. 47–51, 1976. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Lu, H.-Q. Li, D.-L. Fu, G.-Q. Zheng, and J.-P. Fan, “Rhubarb root and rhizome-based Chinese herbal prescriptions for acute ischemic stroke: a systematic review and meta-analysis,” Complementary Therapies in Medicine, vol. 22, no. 6, pp. 1060–1070, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. A.-J. Liu, L. Song, Y. Li et al., “Active compounds of rhubarb root and rhizome in animal model experiments of focal cerebral ischemia,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 210546, 13 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. Z.-W. Wang, M. Guo, D. Ma, and R.-Q. Wang, “Effects of Rhubarbs from different regions on blood lipid and antioxidation of hyperlipidemia rats,” Zhongguo Ying Yong Sheng Li Xue Za Zhi, vol. 31, no. 3, pp. 278–281, 2015. View at Google Scholar · View at Scopus
  15. J. Hayakawa, N. Noda, S. Yamada, E. Mikami, and K. Uno, “Studies on physical chemical quality evaluation of crude drugs preparations. III. Analysis of gardenia fruits and its preparations,” Yakugaku Zasshi, vol. 105, pp. 996–1000, 1986. View at Google Scholar
  16. J. C. Jang, K. S. Lee, Y. S. Kim et al., “Purgative activities of whangryunhaedoktang and chunghyuldanm,” Natural Product Science, vol. 9, pp. 64–67, 2003. View at Google Scholar
  17. H. K. Yang, Y. S. Kim, H. S. Bae et al., “Rhei rhizoma and chunghyuldan inhibit pancreatic lipase,” Natural Product Sciences, vol. 9, no. 1, pp. 38–43, 2003. View at Google Scholar
  18. M. J. Martin, W. S. Browner, S. B. Hulley, L. H. Kuller, and D. Wentworth, “Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361 662 men,” The Lancet, vol. 328, no. 8513, pp. 933–936, 1986. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Stamler, D. Wentworth, and J. D. Neaton, “Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded?. Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT),” The Journal of the American Medical Association, vol. 256, no. 20, pp. 2823–2828, 1986. View at Publisher · View at Google Scholar · View at Scopus
  20. B. J. Ansell, “Cholesterol, stroke risk, and stroke prevention,” Current Atherosclerosis Reports, vol. 2, no. 2, pp. 92–96, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Insull, S. Kafonek, D. Goldner, and F. Zieve, “Comparison of efficacy and safety of atorvastatin (10 mg) with simvastatin (10 mg) at six weeks,” American Journal of Cardiology, vol. 87, no. 5, pp. 554–559, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Black, M. Davidson, M. Koren et al., “Cost effectiveness of treatment to National Cholesterol Education Panel (NCEP) targets with HMG-CoA reductase inhibitors. Trial design,” PharmacoEconomics, vol. 12, no. 2, pp. 278–285, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. K. H. Chung, Y. S. Choi, L. D. Kim et al., “Effects of chunghyul-dan on serum lipids in patients with hyperlipidemia,” Korean Journal of Oriental Internal Medicine, vol. 24, no. 3, pp. 543–550, 2003. View at Google Scholar
  24. T. K. Kim, W. S. Jung, S. W. Park, K. H. Cho, and Y. S. Kim, “Comparison of efficacy and safety between chunghyul-dan (HH-333) and atorvastatin (Lipitor®),” Korean Journal of Oriental Internal Medicine, vol. 24, no. 4, pp. 837–845, 2003. View at Google Scholar
  25. K. H. Cho, H. S. Kang, W. S. Jung, S. U. Park, and S. K. Moon, “Efficacy and safety of Chunghyul-dan (Qingwie-dan) in patients with hypercholesterolemia,” The American Journal of Chinese Medicine, vol. 33, no. 2, pp. 241–248, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. E.-J. Bak, J. Kim, Y. H. Choi et al., “Wogonin ameliorates hyperglycemia and dyslipidemia via PPARα activation in db/db mice,” Clinical Nutrition, vol. 33, no. 1, pp. 156–163, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. K. H. Song, S. H. Lee, B.-Y. Kim, A. Y. Park, and J. Y. Kim, “Extracts of scutellaria baicalensis reduced body weight and blood triglyceride in db/db mice,” Phytotherapy Research, vol. 27, no. 2, pp. 244–250, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Ma, Y. Hu, Z. Zou, M. Feng, X. Ye, and X. Li, “Antihyperglycemia and antihyperlipidemia effect of protoberberine alkaloids from rhizoma coptidis in HepG2 cell and diabetic KK-Ay mice,” Drug Development Research, 2016. View at Publisher · View at Google Scholar
  29. S. Kou, B. Han, Y. Wang et al., “Synergetic cholesterol-lowering effects of main alkaloids from Rhizoma Coptidis in HepG2 cells and hypercholesterolemia hamsters,” Life Sciences, vol. 151, pp. 50–60, 2016. View at Publisher · View at Google Scholar
  30. I.-A. Lee, J. H. Lee, N.-I. Baek, and D.-H. Kim, “Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite crocetin,” Biological and Pharmaceutical Bulletin, vol. 28, no. 11, pp. 2106–2110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. S. P. Yun, L. D. Kim, S. H. Lee et al., “Effects of Chunghyul-dan on stage 1 hypertensive patients with stroke-preliminary study for optimal dose,” Korean Journal of Oriental Internal Medicine, pp. 74–81, 2004. View at Google Scholar
  32. S. P. Yun, W. S. Jung, S. U. Park et al., “Anti-hypertensive effect of Chunghyul-dan (Qingxue-dan) on stroke patients with essential hypertension,” American Journal of Chinese Medicine, vol. 33, no. 3, pp. 357–364, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Sanae, Y. Komatsu, S. Amagaya, K. Chisaki, and H. Hayashi, “Effects of 9 Kampo medicines clinically used in hypertension on hemodynamic changes induced by theophylline in rats,” Biological and Pharmaceutical Bulletin, vol. 23, no. 6, pp. 762–765, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Sanae, Y. Komatsu, K. Chisaki, T. Kido, A. Ishige, and H. Hayashi, “Effects of San'o-shashin-to and the constituent herbal medicines on theophylline-induced increase in arterial blood pressure of rats,” Biological and Pharmaceutical Bulletin, vol. 24, no. 10, pp. 1137–1141, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. H.-H. Tsai, I.-J. Chen, and Y.-C. Lo, “Effects of San-Huang-Xie-Xin-Tang on U46619-induced increase in pulmonary arterial blood pressure,” Journal of Ethnopharmacology, vol. 117, no. 3, pp. 457–462, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Liu, J. Liu, Z. Huang et al., “Berberine improves endothelial function by inhibiting endoplasmic reticulum stress in the carotid arteries of spontaneously hypertensive rats,” Biochemical and Biophysical Research Communications, vol. 458, no. 4, Article ID 33419, pp. 796–801, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. P. F. Davies, “Flow-mediated endothelial mechanotransduction,” Physiological Reviews, vol. 75, no. 3, pp. 519–560, 1995. View at Google Scholar · View at Scopus
  38. K.-H. Cho, W.-S. Jung, S.-U. Park et al., “Daio-Orengedokudo works as a cell-proliferating compound in endothelial cells,” Canadian Journal of Physiology and Pharmacology, vol. 82, no. 6, pp. 380–386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. S.-U. Park, W.-S. Jung, S.-K. Moon et al., “Chunghyuldan activates NOS mRNA expression and suppresses VCAM-1 mRNA expression in human endothelial cells,” Canadian Journal of Physiology and Pharmacology, vol. 83, no. 12, pp. 1101–1108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. W. S. Jung, J. Cho, K. In et al., “Chunghyul-dan acts as an Anti-Inflammatory agent in endothelial cells by regulating gene expression,” Animal Cells and Systems, vol. 14, no. 4, pp. 275–282, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. Y.-L. Chang, J.-J. Shen, B.-S. Wung, J.-J. Cheng, and D. L. Wang, “Chinese herbal remedy wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells,” Molecular Pharmacology, vol. 60, no. 3, pp. 507–513, 2001. View at Google Scholar · View at Scopus
  42. Z. Huang, X. Cai, S. Li et al., “Berberine-attenuated monocyte adhesion to endothelial cells induced by oxidized low-density lipoprotein via inhibition of adhesion molecule expression,” Molecular Medicine Reports, vol. 7, no. 2, pp. 461–465, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. Q. Wang, M. Zhang, B. Liang, N. Shirwany, Y. Zhu, and M.-H. Zou, “Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2,” PLoS ONE, vol. 6, no. 9, Article ID e25436, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. S. U. Park, W. S. Jung, S. K. Moon et al., “Chunghyul-Dan (Qingxie-dan) improves arterial stiffness in patients with increased baPWV,” The American Journal of Chinese Medicine, vol. 34, no. 4, pp. 553–563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Y.-J. Shyy and S. Chien, “Role of integrins in endothelial mechanosensing of shear stress,” Circulation Research, vol. 91, no. 9, pp. 769–775, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. N. M. van Popele, D. E. Grobbee, M. L. Bots et al., “Association between arterial stiffness and atherosclerosis: the Rotterdam Study,” Stroke, vol. 32, no. 2, pp. 454–460, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Taniwaki, T. Kawagishi, M. Emoto et al., “Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes,” Diabetes Care, vol. 22, no. 11, pp. 1851–1857, 1999. View at Publisher · View at Google Scholar · View at Scopus
  48. D. K. Ahn, D. H. Won, and J. H. Kim, “Neuroprotective effects of the Rhei Rhizoma on the Rats' transient forebrain ischemia caused by 4-vessel-occlusion,” Korean Journal of Herbology, vol. 14, no. 1, pp. 111–120, 1999. View at Google Scholar
  49. B. C. Lee, K. H. Leem, Y. O. Kim et al., “Neuroprotective effects of scutellariae radix on the brain ischemia induced by four-vessel occlusion in rats,” Korean Journal of Herbology, vol. 14, no. 2, pp. 89–96, 1999. View at Google Scholar
  50. C. Lv, L. Wang, X. Liu et al., “Geniposide attenuates oligomeric Aβ1 − 42-induced inflammatory response by targeting RAGE-dependent signaling in BV2 cells,” Current Alzheimer Research, vol. 11, no. 5, pp. 430–440, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Lv, L. Wang, X. Liu et al., “Multi-faced neuroprotective effects of geniposide depending on the RAGE-mediated signaling in an Alzheimer mouse model,” Neuropharmacology, vol. 89, pp. 175–184, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. K. N. Nam, H.-J. Jung, M.-H. Kim et al., “Chunghyuldan attenuates brain microglial inflammatory response,” Canadian Journal of Physiology and Pharmacology, vol. 87, no. 6, pp. 448–454, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. K.-H. Cho, J. K. Oh, Y. S. Jang et al., “Combination drug therapy using edaravone and Daio-Orengedoku-to after transient focal ischemia in rats,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 30, no. 6, pp. 443–450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. C.-N. Ko, I.-S. Park, S.-U. Park et al., “Neuroprotective effect of Chunghyuldan (Qing Xue Dan) on hypoxia-reoxygenation induced damage of neuroblastoma 2a cell lines,” Chinese Journal of Integrative Medicine, vol. 19, no. 12, pp. 940–944, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. H. G. Kim, M. S. Ju, D.-H. Kim et al., “Protective effects of Chunghyuldan against ROS-mediated neuronal cell death in models of Parkinson's disease,” Basic & Clinical Pharmacology & Toxicology, vol. 107, no. 6, pp. 958–964, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. K. H. Cho, N. G. Ji, W. S. Jung et al., “Chunghyul-dan for the prevention of stroke progression in silent brain infarction,” The Journal of Korean Oriental Medicine, vol. 26, no. 2, pp. 77–84, 2005. View at Google Scholar
  57. K. H. Cho, N. G. Jee, W. S. Jung et al., “A preliminary study on the inhibitory effect of chunghyul-dan on stroke recurrence in patients with small vessel disease,” The Journal of Korean Oriental Medicine, vol. 28, no. 1, pp. 224–236, 2007. View at Google Scholar
  58. K. Cho, K. Noh, W. Jung et al., “A preliminary study on the inhibitory effect of Chunghyul-dan on stroke recurrence in patients with small vessel disease,” Neurological Research, vol. 30, no. 6, pp. 655–658, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. ESPS Group, “European stroke prevention study,” Stroke, vol. 21, no. 8, pp. 1122–1130, 1990. View at Publisher · View at Google Scholar · View at Scopus
  60. B. Farrell, J. Godwin, S. Richards, and C. Warlow, “The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: Final results,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 54, no. 12, pp. 1044–1054, 1991. View at Publisher · View at Google Scholar · View at Scopus
  61. The SALT Collaborative Group, “Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events,” The Lancet, vol. 338, no. 8779, pp. 1345–1349, 1991. View at Publisher · View at Google Scholar · View at Scopus
  62. H. C. Diener, L. Cunha, C. Forbes, J. Sivenius, P. Smets, and A. Lowenthal, “European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke,” Journal of the Neurological Sciences, vol. 143, no. 1-2, pp. 1–13, 1996. View at Publisher · View at Google Scholar · View at Scopus
  63. P. H.-C. Diener, P. J. Bogousslavsky, P. L. M. Brass et al., “Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial,” The Lancet, vol. 364, no. 9431, pp. 331–337, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Shinohara, Y. Katayama, S. Uchiyama et al., “Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial,” The Lancet Neurology, vol. 9, no. 10, pp. 959–968, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Matías-Guiu, J. M. Ferro, J. Alvarez-Sabín et al., “Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP study: a randomized, double-blind, multicenter trial,” Stroke, vol. 34, no. 4, pp. 840–848, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. G. De Berardis, G. Lucisano, A. D'Ettorre et al., “Association of aspirin use with major bleeding in patients with and without diabetes,” The Journal of the American Medical Association, vol. 307, no. 21, pp. 2286–2294, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. K. H. Cho, W. S. Jung, S. U. Park, S. K. Moon, Y. S. Kim, and H. S. Hae, “Clinical assessment on the safety of chunghyul-dan (Qingwie-dan),” The Journal of Korean Oriental Medicine, vol. 24, no. 3, pp. 45–50, 2003. View at Google Scholar
  68. M. Davidson, J. McKenney, E. Stein et al., “Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia,” The American Journal of Cardiology, vol. 79, no. 11, pp. 1475–1481, 1997. View at Publisher · View at Google Scholar · View at Scopus
  69. S. Bertolini, G. B. Bon, L. M. Campbell et al., “Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia,” Atherosclerosis, vol. 130, no. 1-2, pp. 191–197, 1997. View at Publisher · View at Google Scholar · View at Scopus